Page last updated: 2024-08-21

pyrazines and Sicca Syndrome

pyrazines has been researched along with Sicca Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burmester, GR; Buttgereit, F; Dörner, T; Egerer, K; Faustman, DL; Feist, E; Gaber-Elsner, T; Ghannam, K; Hahne, M; Kloetzel, PM; Kuckelkorn, U; Lesemann, K; Martinez-Gamboa, L; Naumann, L; Scheffler, S	1
Atisha-Fregoso, Y; Jakez-Ocampo, J; Llorente, L	1

Other Studies

2 other study(ies) available for pyrazines and Sicca Syndrome

Article	Year
Gene expression of catalytic proteasome subunits and resistance toward proteasome inhibition of B lymphocytes from patients with primary sjogren syndrome. The Journal of rheumatology, 2013, Volume: 40, Issue:5 Topics: Adult; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Boronic Acids; Bortezomib; Catalytic Domain; Cells, Cultured; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Outpatients; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Subunits; Pyrazines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sjogren's Syndrome	2013
Refractory primary Sjögren syndrome successfully treated with bortezomib. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2015, Volume: 21, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Boronic Acids; Bortezomib; Drug Resistance; Fatigue; Female; Globulins; Humans; Incidence; Proteasome Inhibitors; Pyrazines; Severity of Illness Index; Sjogren's Syndrome; Treatment Outcome	2015

Article

Year

Gene expression of catalytic proteasome subunits and resistance toward proteasome inhibition of B lymphocytes from patients with primary sjogren syndrome.

The Journal of rheumatology, 2013, Volume: 40, Issue:5

Topics: Adult; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Boronic Acids; Bortezomib; Catalytic Domain; Cells, Cultured; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Outpatients; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Subunits; Pyrazines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sjogren's Syndrome

2013

Refractory primary Sjögren syndrome successfully treated with bortezomib.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2015, Volume: 21, Issue:1

Topics: Adrenal Cortex Hormones; Adult; Boronic Acids; Bortezomib; Drug Resistance; Fatigue; Female; Globulins; Humans; Incidence; Proteasome Inhibitors; Pyrazines; Severity of Illness Index; Sjogren's Syndrome; Treatment Outcome

2015